The
herpes treatment market is poised to grow by USD 677.02 million during 2020-2024
progressing at a CAGR of almost 4% during the forecast period.
Technavio suggests three forecast scenarios (optimistic, probable, and
pessimistic) considering the impact of COVID-19. Download Free Sample Report
on COVID-19 Recovery Analysis
The report on the herpes treatment market provides a holistic update,
market size and forecast, trends, growth drivers, and challenges, as well as
vendor analysis.
The report offers an up-to-date analysis regarding the current global
market scenario, the latest trends and drivers, and the overall market
environment. The market is driven by the increasing prevalence of herpes
infection.
The herpes treatment market analysis includes the type segment and
geography landscape. This study identifies the rising prevalence rate of
shingles in the older population as one of the prime reasons driving the herpes
treatment market growth during the next few years.
This report presents a detailed picture of the market by the way of
study, synthesis, and summation of data from multiple sources by an analysis of
key parameters.
The Herpes Treatment Market covers the following areas:
Herpes Treatment Market Sizing
Herpes Treatment Market Forecast
Herpes Treatment Market Analysis
Companies Mentioned
- Bausch Health Companies Inc.
- Cipla Inc.
- Eli Lilly and Co.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Maruho Co. Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis AG
- Teva Pharmaceutical
Industries Ltd.
No comments:
Post a Comment